relapse incidence post-allosct with ptcy for aml in cr1
Published 6 months ago • 87 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
1:40
outcomes & treatment options for patients with aml who relapse after allohsct
-
2:47
management of relapse following allohsct in patients with aml and mds
-
4:28
approaching patients with mds and aml who relapse after allosct & strategies to prevent relapse
-
2:06
preventing relapse post-transplant in aml and mds?
-
2:38
emerging strategies for the management of relapsed aml
-
2:42
the use of targeted therapy to prevent relapse post-transplant
-
3:16
developing patient-specific mrd markers for predicting and preventing mds relapse post-sct
-
14:44
the role of allosct in patients with hl who relapse after autosct and the impact of novel agents
-
8:05
george's story: stem cell transplant for leukaemia
-
3:32
paul's story - after a stem cell transplant
-
6:02
experiencing a relapse in multiple myeloma
-
2:05
donor lymphocyte infusion for relapsed myelofibrosis in the post-allosct setting
-
3:41
managing post-transplant relapse in aml
-
2:14
addressing the high rate of disease relapse following allosct in patients with aml
-
1:45
how to optimally manage relapse in aml
-
1:13
prevention, detection and treatment of aml relapse after allo-sct
-
2:50
investigating relapse after allo-sct in aml
-
4:49
novel transplant strategies in aml and the importance of reducing the risk of relapse in patients
-
1:22
unanswered questions in aml: classification, the role of chemotherapy & avoiding relapse
-
2:33
dli following haplohct ptcy relapse
-
6:22
post-transplant maintenance for patients with aml
-
1:48
managing disease relapse in transplant patients with aml